MarketPeel
Insider Trading Intelligence
TL

Thermopylae Holdings Ltd.

ABCL
10% OWNER · ABCELLERA BIOLOGICS INC. · CIK 0001834449
FILING MIX · LIFETIME72%/28%
BUYS
13
SELLS
5
TOTAL VALUE
$156.07M
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
56,134,097
AVG SELL PX
$24.03
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Thermopylae Holdings Ltd., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+61.54%+5.32%-1.24%+6.56%+2.41%
14d13+61.54%+7.51%-0.16%+7.68%+5.80%
30d13+61.54%+8.07%-2.19%+10.26%-0.90%
60d13+69.23%+24.15%+3.28%+20.87%+11.49%
90d13+76.92%+27.12%+4.09%+19.43%+15.51%
180d13(2 pending)+63.64%+20.52%+3.50%+17.02%+11.59%
1y13(2 pending)+18.18%-8.45%+12.46%-20.91%-24.80%
2y13(4 pending)+0.00%-61.52%+37.98%-99.50%-107.23%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABCL · 56,134,097 shares · as of Feb 27, 2026
014,035,91028,071,82042,107,73056,143,64020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 13 buys / 5 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
38,000$3.44$130.7K56,134,097Feb 27, 2026Mar 2, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
177,457$3.27$580.3K56,096,097Feb 26, 2026Feb 27, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
SALEGRANT
Gift
225,00055,918,640Dec 18, 2025Dec 19, 2025View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
343,631$2.16$742.2K56,143,640Mar 11, 2025Mar 11, 2025View →
ABCL
ABCELLERA BIOLOGICS INC.
SALEGRANT
Gift
286,00055,800,009Dec 4, 2024Dec 5, 2024View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
283,516$2.61$740.0K56,086,009Aug 29, 2024Aug 29, 2024View →
ABCL
ABCELLERA BIOLOGICS INC.
SALEGRANT
Gift
210,00055,802,493Dec 19, 2023Dec 19, 2023View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
153,000$6.52$997.7K56,012,493May 26, 2023May 26, 2023View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
85,102$10.10$859.2K55,859,493Dec 16, 2022Dec 20, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
SALEGRANT
Gift
70,00055,774,391Oct 31, 2022Nov 9, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
200,000$11.46$2.29M55,844,391Aug 19, 2022Aug 22, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
9,173$8.05$73.8K55,644,391Jun 14, 2022Jun 15, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
54,915$8.03$441.1K55,635,218Jun 13, 2022Jun 15, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
64,545$7.50$484.0K55,580,303Jun 6, 2022Jun 8, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
300,000$7.26$2.18M55,515,758May 13, 2022May 17, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
1,408,468$6.41$9.02M55,215,758May 12, 2022May 16, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
202,960$14.76$3.00M55,807,290Nov 11, 2021Nov 15, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
5,598,420$24.03$134.53M55,604,330Jun 9, 2021Jun 10, 2021View →
Other insiders · ABCL
Loading peer insiders…
About this filer
CIK 0001834449
ROLE
10% Owner
PRIMARY
ABCL
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001834449DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback